▶ 調査レポート

世界の急性腎障害治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Acute Kidney Injury Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の急性腎障害治療市場規模・現状・予測(2021年-2027年) / Global Acute Kidney Injury Treatment Market Size, Status and Forecast 2021-2027 / QFJ1-3757資料のイメージです。• レポートコード:QFJ1-3757
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、急性腎障害治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(前腎性急性腎障害、後腎性急性腎障害、内在性腎性急性腎障害)、用途別市場規模(病院、外来外科センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・急性腎障害治療の市場動向
・企業の競争状況、市場シェア
・急性腎障害治療の種類別市場規模と予測2016-2027(前腎性急性腎障害、後腎性急性腎障害、内在性腎性急性腎障害)
・急性腎障害治療の用途別市場規模と予測2016-2027(病院、外来外科センター、その他)
・急性腎障害治療の北米市場規模2016-2027(アメリカ、カナダ)
・急性腎障害治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性腎障害治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性腎障害治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性腎障害治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Quark Pharmaceuticals, Inc.、Baxter International, Inc.、Fresenius Medical Care AG & Co. KGaA、LG Chem、Asahi Kasei Medical Co., Ltd.、B. Braun Melsungen AG、Angion Biomedica Corp)
・結論

Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure.

Market Analysis and Insights: Global Acute Kidney Injury Treatment Market
The global Acute Kidney Injury Treatment market size is projected to reach US$ 1633.3 million by 2027, from US$ 1206.1 million in 2020, at a CAGR of 4.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Kidney Injury Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Kidney Injury Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Kidney Injury Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Kidney Injury Treatment market.

Global Acute Kidney Injury Treatment Scope and Market Size
Acute Kidney Injury Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Kidney Injury Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prerenal Acute Kidney Injury
Postrenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Quark Pharmaceuticals, Inc.
Baxter International, Inc.
Fresenius Medical Care AG & Co. KGaA
LG Chem
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Angion Biomedica Corp

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Kidney Injury Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prerenal Acute Kidney Injury
1.2.3 Postrenal Acute Kidney Injury
1.2.4 Intrinsic Renal Acute Kidney Injury
1.3 Market by Application
1.3.1 Global Acute Kidney Injury Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Kidney Injury Treatment Market Perspective (2016-2027)
2.2 Acute Kidney Injury Treatment Growth Trends by Regions
2.2.1 Acute Kidney Injury Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Kidney Injury Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acute Kidney Injury Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acute Kidney Injury Treatment Industry Dynamic
2.3.1 Acute Kidney Injury Treatment Market Trends
2.3.2 Acute Kidney Injury Treatment Market Drivers
2.3.3 Acute Kidney Injury Treatment Market Challenges
2.3.4 Acute Kidney Injury Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Kidney Injury Treatment Players by Revenue
3.1.1 Global Top Acute Kidney Injury Treatment Players by Revenue (2016-2021)
3.1.2 Global Acute Kidney Injury Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acute Kidney Injury Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Kidney Injury Treatment Revenue
3.4 Global Acute Kidney Injury Treatment Market Concentration Ratio
3.4.1 Global Acute Kidney Injury Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Treatment Revenue in 2020
3.5 Acute Kidney Injury Treatment Key Players Head office and Area Served
3.6 Key Players Acute Kidney Injury Treatment Product Solution and Service
3.7 Date of Enter into Acute Kidney Injury Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Kidney Injury Treatment Breakdown Data by Type
4.1 Global Acute Kidney Injury Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acute Kidney Injury Treatment Forecasted Market Size by Type (2022-2027)

5 Acute Kidney Injury Treatment Breakdown Data by Application
5.1 Global Acute Kidney Injury Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acute Kidney Injury Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Kidney Injury Treatment Market Size (2016-2027)
6.2 North America Acute Kidney Injury Treatment Market Size by Type
6.2.1 North America Acute Kidney Injury Treatment Market Size by Type (2016-2021)
6.2.2 North America Acute Kidney Injury Treatment Market Size by Type (2022-2027)
6.2.3 North America Acute Kidney Injury Treatment Market Size by Type (2016-2027)
6.3 North America Acute Kidney Injury Treatment Market Size by Application
6.3.1 North America Acute Kidney Injury Treatment Market Size by Application (2016-2021)
6.3.2 North America Acute Kidney Injury Treatment Market Size by Application (2022-2027)
6.3.3 North America Acute Kidney Injury Treatment Market Size by Application (2016-2027)
6.4 North America Acute Kidney Injury Treatment Market Size by Country
6.4.1 North America Acute Kidney Injury Treatment Market Size by Country (2016-2021)
6.4.2 North America Acute Kidney Injury Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute Kidney Injury Treatment Market Size (2016-2027)
7.2 Europe Acute Kidney Injury Treatment Market Size by Type
7.2.1 Europe Acute Kidney Injury Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acute Kidney Injury Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acute Kidney Injury Treatment Market Size by Type (2016-2027)
7.3 Europe Acute Kidney Injury Treatment Market Size by Application
7.3.1 Europe Acute Kidney Injury Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acute Kidney Injury Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acute Kidney Injury Treatment Market Size by Application (2016-2027)
7.4 Europe Acute Kidney Injury Treatment Market Size by Country
7.4.1 Europe Acute Kidney Injury Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acute Kidney Injury Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Kidney Injury Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acute Kidney Injury Treatment Market Size by Type
8.2.1 Asia-Pacific Acute Kidney Injury Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Kidney Injury Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Kidney Injury Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Kidney Injury Treatment Market Size by Application
8.3.1 Asia-Pacific Acute Kidney Injury Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Kidney Injury Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Kidney Injury Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Kidney Injury Treatment Market Size by Region
8.4.1 Asia-Pacific Acute Kidney Injury Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Kidney Injury Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Kidney Injury Treatment Market Size (2016-2027)
9.2 Latin America Acute Kidney Injury Treatment Market Size by Type
9.2.1 Latin America Acute Kidney Injury Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acute Kidney Injury Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acute Kidney Injury Treatment Market Size by Type (2016-2027)
9.3 Latin America Acute Kidney Injury Treatment Market Size by Application
9.3.1 Latin America Acute Kidney Injury Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acute Kidney Injury Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acute Kidney Injury Treatment Market Size by Application (2016-2027)
9.4 Latin America Acute Kidney Injury Treatment Market Size by Country
9.4.1 Latin America Acute Kidney Injury Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acute Kidney Injury Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Kidney Injury Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acute Kidney Injury Treatment Market Size by Type
10.2.1 Middle East & Africa Acute Kidney Injury Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Kidney Injury Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Kidney Injury Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Kidney Injury Treatment Market Size by Application
10.3.1 Middle East & Africa Acute Kidney Injury Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Kidney Injury Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Kidney Injury Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Kidney Injury Treatment Market Size by Country
10.4.1 Middle East & Africa Acute Kidney Injury Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Kidney Injury Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Quark Pharmaceuticals, Inc.
11.1.1 Quark Pharmaceuticals, Inc. Company Details
11.1.2 Quark Pharmaceuticals, Inc. Business Overview
11.1.3 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Introduction
11.1.4 Quark Pharmaceuticals, Inc. Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.1.5 Quark Pharmaceuticals, Inc. Recent Development
11.2 Baxter International, Inc.
11.2.1 Baxter International, Inc. Company Details
11.2.2 Baxter International, Inc. Business Overview
11.2.3 Baxter International, Inc. Acute Kidney Injury Treatment Introduction
11.2.4 Baxter International, Inc. Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.2.5 Baxter International, Inc. Recent Development
11.3 Fresenius Medical Care AG & Co. KGaA
11.3.1 Fresenius Medical Care AG & Co. KGaA Company Details
11.3.2 Fresenius Medical Care AG & Co. KGaA Business Overview
11.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Introduction
11.3.4 Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.3.5 Fresenius Medical Care AG & Co. KGaA Recent Development
11.4 LG Chem
11.4.1 LG Chem Company Details
11.4.2 LG Chem Business Overview
11.4.3 LG Chem Acute Kidney Injury Treatment Introduction
11.4.4 LG Chem Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.4.5 LG Chem Recent Development
11.5 Asahi Kasei Medical Co., Ltd.
11.5.1 Asahi Kasei Medical Co., Ltd. Company Details
11.5.2 Asahi Kasei Medical Co., Ltd. Business Overview
11.5.3 Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Introduction
11.5.4 Asahi Kasei Medical Co., Ltd. Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.5.5 Asahi Kasei Medical Co., Ltd. Recent Development
11.6 B. Braun Melsungen AG
11.6.1 B. Braun Melsungen AG Company Details
11.6.2 B. Braun Melsungen AG Business Overview
11.6.3 B. Braun Melsungen AG Acute Kidney Injury Treatment Introduction
11.6.4 B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.6.5 B. Braun Melsungen AG Recent Development
11.7 Angion Biomedica Corp
11.7.1 Angion Biomedica Corp Company Details
11.7.2 Angion Biomedica Corp Business Overview
11.7.3 Angion Biomedica Corp Acute Kidney Injury Treatment Introduction
11.7.4 Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment Business (2016-2021)
11.7.5 Angion Biomedica Corp Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Kidney Injury Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prerenal Acute Kidney Injury
Table 3. Key Players of Postrenal Acute Kidney Injury
Table 4. Key Players of Intrinsic Renal Acute Kidney Injury
Table 5. Global Acute Kidney Injury Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Kidney Injury Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Kidney Injury Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute Kidney Injury Treatment Market Share by Regions (2016-2021)
Table 9. Global Acute Kidney Injury Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute Kidney Injury Treatment Market Share by Regions (2022-2027)
Table 11. Acute Kidney Injury Treatment Market Trends
Table 12. Acute Kidney Injury Treatment Market Drivers
Table 13. Acute Kidney Injury Treatment Market Challenges
Table 14. Acute Kidney Injury Treatment Market Restraints
Table 15. Global Acute Kidney Injury Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute Kidney Injury Treatment Market Share by Players (2016-2021)
Table 17. Global Top Acute Kidney Injury Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Treatment as of 2020)
Table 18. Ranking of Global Top Acute Kidney Injury Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute Kidney Injury Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Kidney Injury Treatment Product Solution and Service
Table 22. Date of Enter into Acute Kidney Injury Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Kidney Injury Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute Kidney Injury Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Acute Kidney Injury Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute Kidney Injury Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute Kidney Injury Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute Kidney Injury Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Acute Kidney Injury Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute Kidney Injury Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute Kidney Injury Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute Kidney Injury Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute Kidney Injury Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute Kidney Injury Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Kidney Injury Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute Kidney Injury Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute Kidney Injury Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute Kidney Injury Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute Kidney Injury Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute Kidney Injury Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute Kidney Injury Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute Kidney Injury Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute Kidney Injury Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute Kidney Injury Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Kidney Injury Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Kidney Injury Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Kidney Injury Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute Kidney Injury Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute Kidney Injury Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute Kidney Injury Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute Kidney Injury Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute Kidney Injury Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute Kidney Injury Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute Kidney Injury Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute Kidney Injury Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute Kidney Injury Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Kidney Injury Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Kidney Injury Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Kidney Injury Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute Kidney Injury Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Quark Pharmaceuticals, Inc. Company Details
Table 63. Quark Pharmaceuticals, Inc. Business Overview
Table 64. Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Product
Table 65. Quark Pharmaceuticals, Inc. Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 66. Quark Pharmaceuticals, Inc. Recent Development
Table 67. Baxter International, Inc. Company Details
Table 68. Baxter International, Inc. Business Overview
Table 69. Baxter International, Inc. Acute Kidney Injury Treatment Product
Table 70. Baxter International, Inc. Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 71. Baxter International, Inc. Recent Development
Table 72. Fresenius Medical Care AG & Co. KGaA Company Details
Table 73. Fresenius Medical Care AG & Co. KGaA Business Overview
Table 74. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Product
Table 75. Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 76. Fresenius Medical Care AG & Co. KGaA Recent Development
Table 77. LG Chem Company Details
Table 78. LG Chem Business Overview
Table 79. LG Chem Acute Kidney Injury Treatment Product
Table 80. LG Chem Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 81. LG Chem Recent Development
Table 82. Asahi Kasei Medical Co., Ltd. Company Details
Table 83. Asahi Kasei Medical Co., Ltd. Business Overview
Table 84. Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Product
Table 85. Asahi Kasei Medical Co., Ltd. Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 86. Asahi Kasei Medical Co., Ltd. Recent Development
Table 87. B. Braun Melsungen AG Company Details
Table 88. B. Braun Melsungen AG Business Overview
Table 89. B. Braun Melsungen AG Acute Kidney Injury Treatment Product
Table 90. B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 91. B. Braun Melsungen AG Recent Development
Table 92. Angion Biomedica Corp Company Details
Table 93. Angion Biomedica Corp Business Overview
Table 94. Angion Biomedica Corp Acute Kidney Injury Treatment Product
Table 95. Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment Business (2016-2021) & (US$ Million)
Table 96. Angion Biomedica Corp Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Kidney Injury Treatment Market Share by Type: 2020 VS 2027
Figure 2. Prerenal Acute Kidney Injury Features
Figure 3. Postrenal Acute Kidney Injury Features
Figure 4. Intrinsic Renal Acute Kidney Injury Features
Figure 5. Global Acute Kidney Injury Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Kidney Injury Treatment Report Years Considered
Figure 10. Global Acute Kidney Injury Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Kidney Injury Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Kidney Injury Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Kidney Injury Treatment Market Share by Regions (2022-2027)
Figure 14. Global Acute Kidney Injury Treatment Market Share by Players in 2020
Figure 15. Global Top Acute Kidney Injury Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Kidney Injury Treatment Revenue in 2020
Figure 17. Global Acute Kidney Injury Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Kidney Injury Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Kidney Injury Treatment Market Share by Type (2016-2027)
Figure 21. North America Acute Kidney Injury Treatment Market Share by Application (2016-2027)
Figure 22. North America Acute Kidney Injury Treatment Market Share by Country (2016-2027)
Figure 23. United States Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Kidney Injury Treatment Market Share by Type (2016-2027)
Figure 27. Europe Acute Kidney Injury Treatment Market Share by Application (2016-2027)
Figure 28. Europe Acute Kidney Injury Treatment Market Share by Country (2016-2027)
Figure 29. Germany Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Kidney Injury Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Kidney Injury Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Kidney Injury Treatment Market Share by Region (2016-2027)
Figure 39. China Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Kidney Injury Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Acute Kidney Injury Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Acute Kidney Injury Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Kidney Injury Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Kidney Injury Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Kidney Injury Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Kidney Injury Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Quark Pharmaceuticals, Inc. Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 59. Baxter International, Inc. Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 60. Fresenius Medical Care AG & Co. KGaA Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 61. LG Chem Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 62. Asahi Kasei Medical Co., Ltd. Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 63. B. Braun Melsungen AG Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 64. Angion Biomedica Corp Revenue Growth Rate in Acute Kidney Injury Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed